Gut Microbiome Linked to Macrocephaly in NF1 Mouse Model

Neurofibromatosis type 1 (NF1) is a complex multisystem disorder in which cognitive impairment and autism spectrum behaviors frequently complicate clinical management. While the genetic etiology is well defined, the significant phenotypic variability in neurological symptoms suggests that systemic factors beyond the germline mutation influence disease expression [1]. Recent evidence highlights the gut-brain-immune axis as a critical regulator of neurodevelopment and behavior, with microbial dysbiosis (an imbalance in the intestinal bacterial community) implicated in various neurodevelopmental conditions [2]. In related oncological contexts, the intestinal microbiota has already been shown to modulate the growth of optic gliomas in patients with this condition [3]. Furthermore, sex-dependent differences in gut-brain signaling appear to play a significant role in the manifestation of social and behavioral deficits [4]. To better understand these mechanisms, researchers recently examined how specific microbial populations might drive the structural brain changes and behavioral phenotypes characteristic of this genetic syndrome, raising the possibility of eventually targeting the microbiome to manage cognitive symptoms.